C17 LYSO PAF

Code: 878101P-10MG D2-231

General description

C17 Lyso PAF, also known as 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a precursor and metabolite of 1-O-heptadecyl-2-acetyl-sn-glycero-3-ph...


read more

Your Price
€419.90 10MG
€516.48 inc. VAT

General description

C17 Lyso PAF, also known as 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a precursor and metabolite of 1-O-heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. It is also synthesized from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine; PC) by the enzyme phospholipase A2 via the remodeling pathway.

Packaging

5 mL Amber Glass Screw Cap Vial (878101P-10mg)

formpowder
manufacturer/tradenameAvanti Polar Lipids 878101P
packagingpkg of 1 × 10 mg (878101P-10mg)
shipped indry ice
SMILES stringO[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCCC
storage temp.−20°C
Cas Number111858-52-7
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.